Bill
SD 922
Overview: SD 922, "An Act relative to expanding the newborn screening panel", has passed the House and is awaiting the Governor's signature. It was introduced on February 27, 2025.
Overview: SD 922, "An Act relative to expanding the newborn screening panel", has passed the House and is awaiting the Governor's signature. It was introduced on February 27, 2025.
Purpose and Intent: The bill aims to expand the state's newborn screening panel to include additional genetic and metabolic disorders. This would ensure earlier detection and treatment of a wider range of potentially serious conditions, improving health outcomes for newborns.
Key Provisions:
- Adds 10 new disorders to the mandatory newborn screening panel
- Requires the Department of Public Health to periodically review and update the screening panel based on medical advancements
- Provides funding to support the expanded screening program and follow-up care
Affected Parties and Impacts: All newborns in the state would be subject to the expanded screening, leading to earlier diagnosis and treatment of a broader range of genetic and metabolic disorders. This could significantly improve long-term health and quality of life for affected children and their families.
Procedural and Timeline Considerations: The bill has passed both the House and Senate and is now awaiting the Governor's signature to be enacted into law. Once signed, the expanded newborn screening program would take effect within 6 months to allow for implementation.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
